The global pharmaceutical contract development & manufacturing organization (CDMO) market, valued at USD 192.19 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 8.11% through 2034, driven by intensifying regional disparities in regulatory frameworks, supply chain localization mandates, and strategic capacity reallocation. North America continues to dominate...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek